Clinical Trial: Development of a Machine Learning-Based Predictive Model for Financial Toxicity in Lung Cancer and Formulation of Corresponding Intervention Strategies (China)

China, Oct. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of a Machine Learning-Based Predictive Model for Financial Toxicity in Lung Cancer and Formulation of Corresponding Intervention Strategies'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134387

Registration Time: 2026/10/14

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Nanchang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345130

Published by HT Digital Content Services with permission from Health Daily Digest....